Ifosfamide
Back to searchMolecule Structure
Scientific Name
Ifosfamide
Description of the Drug
Ifosfamide is an alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteocarcinoma, bladder cancer, small cell lung cancer, and non-Hodgkin’s lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01181
http://www.drugbank.ca/drugs/DB01181
Brand Name(s)
Ifex, Ifosfamide, Ifsofamide, Mitoxana
Company Owner(s)
Hikma Pharmaceuticals Usa Inc, Teva Pharmaceuticals Usa, Fresenius Kabi Usa Llc, Baxter Healthcare Corp, Mylan Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4885 | |||
| PharmGKB | PA449964 | |||
| Human Metabolome Database | HMDB0015312 | |||
| WDI | IFOSFAMID | |||
| DrugBank | DB01181 | |||
| PubChem: Thomson Pharma | 14823762 | |||
| PubChem | 3690 | |||
| Mcule | MCULE-1480299331 | |||
| LINCS | LSM-5118 | |||
| Nikkaji | J599.677E | J2.196B | J26.476H | J599.676G |
| BindingDB | 189358 | |||
| EPA CompTox Dashboard | DTXSID7020760 | |||
| DrugCentral | 1421 | |||
| Brenda | 143769 | |||
| ChemicalBook | CB7489350 | |||
| Guide to Pharmacology | 7201 | |||
| GSRS | e46b62c3-128b-4464-a71f-36ad6464fb9b | |||
| rxnorm | IFEX | IFOSFAMIDE | ||
| KEGG Ligand | C07047 | |||
| ChEBI | 5864 |
